Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220.8 USD | -1.76% | -3.23% | -6.62% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.62% | 1.16TCr | |
+34.04% | 5.08TCr | |
+0.38% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+10.94% | 2.61TCr | |
-21.97% | 1.91TCr | |
+8.79% | 1.31TCr | |
+27.06% | 1.22TCr | |
+24.38% | 1.21TCr |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Citigroup Adjusts Price Target on Charles River Laboratories to $215 From $190, Keeps Neutral Rating